Immune complex size and complement regulate cytokine production by peripheral blood mononuclear cells

J N Jarvis1, C Xu, W Wang

  • 1Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma 73013, USA. james-jarvis@ouhsc.edu

Insights

Immune complex size and complement interaction influence inflammation. Larger immune complexes and those without complement activation induced greater inflammatory cytokine release in juvenile rheumatoid arthritis research.

Area of Science:

  • Immunology
  • Rheumatology
  • Cellular Biology

Background:

  • Immune complexes in juvenile rheumatoid arthritis (JRA) exhibit variable size, composition, and inflammatory potential.
  • Understanding the factors governing immune complex proinflammatory effects is crucial for JRA pathogenesis.

Purpose of the Study:

  • To elucidate the specific roles of size and composition in immune complex-mediated inflammation.
  • To investigate how complement influences the inflammatory capacity of immune complexes.

Main Methods:

  • Incubation of peripheral blood mononuclear cells (PBMCs) with distinct immune complex preparations (opsonized, unopsonized, complement-solubilized).
  • Enzyme-linked immunosorbent assay (ELISA) to quantify IL-1beta and IL-8 secretion.
  • Sucrose density gradient ultracentrifugation to assess immune complex size.
  • Complement component C4 binding assays.

Main Results:

  • Immune complexes formed with complement were less potent inducers of IL-1beta and IL-8 than unopsonized complexes.
  • Complement-solubilized immune precipitates demonstrated intermediate cytokine induction capacity.
  • Unopsonized complexes and solubilized precipitates were larger than opsonized complexes.
  • Fluid-phase C4 binding, without altering size, enhanced IL-1beta secretion.

Conclusions:

  • Complement significantly modulates the inflammatory response to immune complexes, partly through size regulation.
  • Immune complex size is a critical determinant of their capacity to stimulate leukocyte cytokine secretion.
  • Further research into complement's role in JRA immune complexes is warranted.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...